The treatment of juvenile myoclonic epilepsy.
Juvenile myoclonic epilepsy is a common type of epilepsy with onset occurring during adolescence. This review provides a collection of evidence relating to the treatment of this type of epilepsy. Historically, the large majority of patients become seizure-free when treated with valproate. Over recent years, there has been a marked improvement in the pharmacological armamentarium by the physicians. Currently, administration of new antiepileptic drugs, such as levetiracetam, lamotrigine and topiramate, seems to have beneficial effects in the patients with poor response to valproate.
Verrotti
Alberto
A
University of Chieti, Alberto Verrotti Dept. of Pediatrics, University of Chieti Ospedale Policlinico, Via dei Vestini 5, Italy. averrott@unich.it
Manco
Rossella
R
di Marco
Giovanna
G
Chiarelli
Francesco
F
Franzoni
Emilio
E
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D006801:Humans; D020190:Myoclonic Epilepsy, Juvenile / Q000188:drug therapy*
D000927:Anticonvulsants